» Articles » PMID: 35073997

The Role and Therapeutic Potential of Stem Cells in Skeletal Muscle in Sarcopenia

Overview
Publisher Biomed Central
Date 2022 Jan 25
PMID 35073997
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcopenia is a common age-related skeletal muscle disorder featuring the loss of muscle mass and function. In regard to tissue repair in the human body, scientists always consider the use of stem cells. In skeletal muscle, satellite cells (SCs) are adult stem cells that maintain tissue homeostasis and repair damaged regions after injury to preserve skeletal muscle integrity. Muscle-derived stem cells (MDSCs) and SCs are the two most commonly studied stem cell populations from skeletal muscle. To date, considerable progress has been achieved in understanding the complex associations between stem cells in muscle and the occurrence and treatment of sarcopenia. In this review, we first give brief introductions to sarcopenia, SCs and MDSCs. Then, we attempt to untangle the differences and connections between these two types of stem cells and further elaborate on the interactions between sarcopenia and stem cells. Finally, our perspectives on the possible application of stem cells for the treatment of sarcopenia in future are presented. Several studies emerging in recent years have shown that changes in the number and function of stem cells can trigger sarcopenia, which in turn leads to adverse influences on stem cells because of the altered internal environment in muscle. A better understanding of the role of stem cells in muscle, especially SCs and MDSCs, in sarcopenia will facilitate the realization of novel therapy approaches based on stem cells to combat sarcopenia.

Citing Articles

Puerarin Promotes the Migration and Differentiation of Myoblasts by Activating the FAK and PI3K/AKT Signaling Pathways.

Fang X, Xu H, Fan Z, Yang H, Huang Y, Xu L Biology (Basel). 2025; 14(1).

PMID: 39857332 PMC: 11763015. DOI: 10.3390/biology14010102.


Durable Muscle Extracellular Matrix Engineered with Adhesive Phenolic Moieties for Effective Skeletal Muscle Regeneration in Muscle Atrophy.

Choi S, Lee M, Kim M, Bae Y, Park J, Cho S Adv Healthc Mater. 2024; 13(32):e2401826.

PMID: 39420690 PMC: 11670296. DOI: 10.1002/adhm.202401826.


Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview.

Najm A, Moldoveanu E, Niculescu A, Grumezescu A, Beuran M, Gaspar B Int J Mol Sci. 2024; 25(19).

PMID: 39409095 PMC: 11476378. DOI: 10.3390/ijms251910766.


FOXO-regulated DEAF1 controls muscle regeneration through autophagy.

Goh K, Lee W, Choy S, Priyadarshini G, Chua K, Tan Q Autophagy. 2024; 20(12):2632-2654.

PMID: 38963021 PMC: 11587838. DOI: 10.1080/15548627.2024.2374693.


Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration.

Budzynska K, Siemionow M, Stawarz K, Chambily L, Siemionow K Biomolecules. 2024; 14(5).

PMID: 38785982 PMC: 11117592. DOI: 10.3390/biom14050575.


References
1.
Robles P, Sussman M, Naraghi A, Brooks D, Goldstein R, White L . Intramuscular Fat Infiltration Contributes to Impaired Muscle Function in COPD. Med Sci Sports Exerc. 2014; 47(7):1334-41. DOI: 10.1249/MSS.0000000000000556. View

2.
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D . Oxidative stress, aging, and diseases. Clin Interv Aging. 2018; 13:757-772. PMC: 5927356. DOI: 10.2147/CIA.S158513. View

3.
Atkins H . Stem Cell Transplantation to Treat Multiple Sclerosis. JAMA. 2019; 321(2):153-155. DOI: 10.1001/jama.2018.20777. View

4.
Jackson K, Mi T, Goodell M . Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A. 1999; 96(25):14482-6. PMC: 24462. DOI: 10.1073/pnas.96.25.14482. View

5.
Dent E, Morley J, Cruz-Jentoft A, Arai H, Kritchevsky S, Guralnik J . International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018; 22(10):1148-1161. DOI: 10.1007/s12603-018-1139-9. View